Briefcase

From Bedside to Webside: Providing Optimal Care for NVAF Patients via Telemedicine

Launch Date
05/06/2021
Credit Amount
0.00 Expired
Credit Expires
05/06/2022
This activity is part of a series

Faculty

Mintu P. Turakhia, MD, MAS
Associate Professor
Executive Director, Center for Digital Health, Stanford University School of Medicine
Director of Cardiac Electrophysiology, VA Palo Alto Health Care System, Palo Alto, CA
Mintu P. Turakhia, MD, MAS

Mintu Turakhia, MD, MAS, is a cardiac electrophysiologist, outcomes researcher, and clinical trialist. He is the Director of the Stanford Center for Digital Health (CDH) and the newly-formed American Heart Association-funded Heart Health Technology Center. In his clinical role, he performs invasive procedures such as catheter ablation and device implantation to treat heart rhythm disorders.

Dr. Turakhia has an active multidisciplinary program in heart rhythm and digital health research, where he uses biostatistical, health economic, artificial intelligence, and data science approaches to examine quality, outcomes, and risk of heart rhythm disorders such as atrial fibrillation in very large datasets. He is a principal investigator of several multi-center trials, such as the Apple Heart Study, to test digital health tools and wearables, and he collaborates closely on research with medical device and technology companies. Dr. Turakhia has published over 200 manuscripts and is an elected member of the American Society for Clinical Investigation, and a Fellow of the American College of Cardiology, American Heart Association, and Heart Rhythm Society. Dr. Turakhia has served as an advisor and investor to over 25 medical device, drug, and health technology companies across their life cycle, from early stage to IPO.

Christian T. Ruff, MD, MPH
Director, General Cardiology, Cardiovascular Division, Brigham and Women's Hospital
Associate Professor of Medicine, Harvard Medical School, Senior Investigator, TIMI Study Group, Boston, MA
Christian T. Ruff, MD, MPH

Christian T. Ruff, MD, MPH is currently the Director of General Cardiology in the Cardiovascular Division at Brigham and Women’s Hospital in Boston, MA and an Associate Professor of Medicine at Harvard Medical School.

Dr. Ruff graduated from Harvard University, earned his medical degree at Johns Hopkins University School of Medicine, and his Masters of Public Health from the Harvard School of Public Health. Dr. Ruff completed his internal medicine residency and cardiovascular medicine fellowship at the Brigham and Women’s Hospital.

Dr. Ruff is a senior investigator in the Thrombolysis in Myocardial Infarction (TIMI) Study Group and serves the Director of the Genetics Core Laboratory and the Co-Chairman of the Clinical Events Committee. He has led a broad array of projects, ranging from investigator-initiated studies of biomarkers and genetic variants to large clinical trials. Dr. Ruff has investigated the efficacy of safety of antithrombotic therapies across the spectrum of cardiovascular disease, with a focus on stroke prevention in atrial fibrillation.

Dr. Ruff has served on international clinical guideline committees and has been invited to give hundreds of lectures nationally and internationally. He has authored many scholarly articles, editorials, reviews, and book chapters that include the New England Journal of Medicine, Lancet, Journal of the American Medical Association, American Journal of Medicine, Circulation, Journal of the American College of Cardiology, and Nature Reviews Cardiology.

Margot Savoy, MD, MPH, FAAFP, FABC, CPE, CMQ, FAAPL
Associate Professor, Department of Family and Community Medicine
Lewis Katz School of Medicine at Temple University, Philadelphia, PA
Margot Savoy, MD, MPH, FAAFP, FABC, CPE, CMQ, FAAPL

Margot Savoy, MD, MPH, FAAFP, FABC, CPE, CMQ, FAAPL is Associate Professor for the Department of Family & Community Medicine at the Lewis Katz School of Medicine at Temple University and Temple University Hospital, and Chief Quality Officer for the Temple Faculty Practice Plan. She is an attending physician at Temple University Hospital (Philadelphia, PA) and Christiana Care Health System (Wilmington, DE). Dr. Savoy graduated from the University of Maryland School of Medicine in 2002, completed Family Medicine Residency Program at the Crozer-Keystone Family Medicine Residency Program (Springfield, PA) in 2005, and graduated from the University of North Carolina Chapel Hill Gillings School of Global Public Health in 2008 with a Master’s degree in Public Health in Public Health Leadership with a focus on Public Health Practice. She is certified by the American Board of Family Medicine, the Certifying Commission in Medical Management, and is a Fellow of the Advisory Board Company.

Explore By Section
Statement of Need Learning Objectives Financial Support Target Audience Credit Information Disclosure Declaration Additional Formats

Statement of Need

When managing patients newly diagnosed with nonvalvular atrial fibrillation (NVAF), it is imperative for clinicians to discuss the diagnosis, evaluate individual stroke and bleeding risks, and use this information to guide therapeutic decisions. Counseling patients on a new NVAF diagnosis and discussing the need for stroke preventive therapy and available treatment options is a critical part of NVAF management that can be challenging when providing care via telemedicine.

This CME Outfitters BriefCase focuses on managing patients with NVAF via telemedicine, including discussion on treatment, clinical efficacy and safety of oral anticoagulants, selecting appropriate anticoagulation at the appropriate dose, applying the latest recommendations for patients who have undergone PCI, and how to implement best practices for a “webside manner” when providing virtual, telemedicine care.

Learning Objectives

At the end of this CME/CE activity, participants should be able to apply best practices for management of stroke risk in patients with NVAF when providing care via telemedicine.

The following learning objectives pertain only to those requesting CNE or CPE credit: Summarize best practices for management of stroke risk in patients with NVAF when providing care via telemedicine.

Financial Support

Supported by an educational grant from the Bristol Myers Squibb and Pfizer Alliance.

Target Audience

Primary care physicians, cardiologists, PAs, nurse practitioners, and pharmacists.

Credit Information

Physicians (ACCME)

CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. CME Outfitters, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacists/Pharmacy Tech (ACPE)

This application-based activity is approved for 1.0 contact hour (0.10 CEUs) of continuing pharmacy credit.

Note to Nurse Practitioners

Nurse Practitioners can apply for AMA PRA Category 1 Credit ™ through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit ™ from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.

ABIM MOC

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Royal College MOC

Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

MIPS Improvement Activity

This activity counts towards MIPS Improvement Activity requirements under the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.

Note to PAs

AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit ™ from organizations accredited by the Accreditation Council for Continuing Medical Education.

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. Turakhia reports that he receives grants from the American Heart Association; Apple Inc.; Bayer; Boehringer Ingelheim; Bristol Myers Squibb Company; Cardiva Medical, Inc.; Janssen Pharmaceuticals, Inc.; and SentreHEART, Inc. He is a consultant for Abbott; BIOTRONIK, Inc.; Cardiva Medical, Inc.; iRhythm Technologies, Inc.; Johnson & Johnson; Medtronic; Milestone Pharmaceuticals, Inc.; MyoKardia, Inc.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; and Sanofi. He receives other financial or material support as an editor for JAMA Cardiology.

Dr. Ruff reports that he receives research grants to the TIMI Study Group through Brigham and Women’s Hospital: Anthos Therapeutics; AstraZeneca; Boehringer Ingelheim; Daiichi Sankyo, Inc.; and National Institutes of Health. He is on Scientific Ad Boards and a consultant for Anthos Therapeutics; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb Company; Daiichi Sankyo, Inc.; Janssen Pharmaceuticals, Inc.; Pfizer Inc.; and Portola Pharmaceuticals, Inc.

Dr. Savoy has no disclosures to report.

Jeffrey Helfand, DO (peer reviewer) has no disclosures to report.

Mae Ochoa, RPh (peer reviewer) has no disclosures to report.

Maria Glukhovsky, PharmD (planning committee) has no disclosures to report.

Jan Perez (planning committee) has no disclosures to report.

Sharon Tordoff (planning committee) has no disclosures to report.

Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

Additional Formats

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit our Privacy & Confidentiality page.

NOTE: Pharmacist CE Universal Activity Number, Enduring: JA0007185-0000-21-111-H01-P

 

Questions about this activity?

Call us at (877) CME-PROS or (877) 263-7767.

 

 

BC-035-050621-90

Activities in the Series

Virtual Education
04/26/2021

Can You Hear Me Now? Engaging Patients in Virtual Shared Decision-Making

0.00 Expired
Begin Learn More
Cardiology
04/23/2021

Hearing a Heartbeat from Miles Away: Remote Detection of Undiagnosed AF

0.00 Expired
Begin Learn More
From Bedside to Webside: Providing Optimal Care for NVAF Patients via Telemedicine
Event Date: 05/06/2021
Begin